- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
NBSGW Mouse Model
| Strain Name | NBSGW Mouse Model (M60027) |
|---|---|
| Editing Type | Combined background: NOD (polygenic) + Prkdc^scid + Kit^W41 (hypomorphic point mutation) + Il2rg^null |
| Gene Name | Prkdc / Kit / Il2rg |
| Gene Synonyms | Prkdc: scid / DNA-PKcs / DNAPK;Kit: W / CD117 / c-KIT;Il2rg: gc / p64 / CD132 / gamma(c) |
| Strain Background | NOD/ShiLtJ-derived, carrying a C57BL/6-derived Kit^W41 interval |
| NCBI No. | Prkdc: Gene ID: 19090 / MGI:104779 |

1. Human HSC transplantation and expansion Providing optimized, radiation-free niche support for transplanted human CD34+ hematopoietic stem cells, and studying their homing, engraftment, proliferation, differentiation and long-term reconstitution kinetics in vivo; evaluating the in vivo function and efficacy of ex vivo expansion protocols, gene modification strategies and conditioning regimens.
2. Humanized immune system reconstitution Transplanting human CD34+ HSCs to rebuild a humanized immune system comprising myeloid, B, T and NK lineages in mice, for studying human immune development, immune responses and immune-related disease.
3. Hematological malignancy and immunotherapy assessment Engrafting patient-derived primary acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and other hematological tumor cells to establish humanized leukemia PDX models, for evaluating targeted therapy and immunotherapy such as CAR-T and bispecific antibodies.
4. Infectious disease and vaccine research Within the reconstituted humanized immune system, studying infection, pathogenesis and in vivo evaluation of vaccines and drugs against human-specific pathogens such as HIV, EBV and Plasmodium.
The NBSGW mouse model is a severely immunodeficient strain built from several combined genetic modifications: a NOD background, the SCID mutation, a Kit point mutation (W41, c-Kit W41) and knockout of the IL-2 receptor gamma chain (Il2rg). The name reflects these features — NOD background, SCID mutation, c-Kit W41, and Il2rg deletion. The key advantage lies in the Kit W41 hypomorphic allele, which reduces competitive niche occupancy by endogenous mouse hematopoietic stem cells, together with the Il2rg deletion, which produces profound combined deficiency of both innate and adaptive immunity. This combination allows NBSGW mice to efficiently support engraftment, expansion and multilineage differentiation of human CD34+ HSCs without toxic myeloablative preconditioning such as total body irradiation (TBI) or chemotherapeutic agents, achieving high-level, long-term and stable reconstitution of human hematopoiesis and immunity. The model markedly reduces the reliance on radiation and its side effects seen in conventional humanized models, improving experimental standardization and reproducibility, and serves as an advanced platform for studying human hematopoiesis, immunity, blood diseases and immunotherapy.
- Engraftment without irradiation. The Kit W41 allele lowers endogenous HSC competitiveness, so the niche is open without TBI — no radiation damage to the host, no radiation-induced artefacts in the readout, and better batch-to-batch reproducibility.
- Deep, combined immunodeficiency. Il2rg loss removes the common gamma chain shared by the IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 receptors, blocking T, B and NK development and leaving engrafted human cells without a competing mouse immune response.
- Multilineage, long-term reconstitution. Myeloid, B, T and NK lineages are all recoverable from a single CD34+ transplant — what makes the model usable for immune development questions rather than just engraftment counts.
- PDX-ready for blood malignancies. Patient AML and ALL cells engraft without a preconditioning step, so primary tumor material is not lost to radiation toxicity.
- A clean platform for human-specific pathogens. HIV, EBV and Plasmodium need human target cells; a reconstituted human immune compartment supplies them inside a host that tolerates human cells.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
